Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Oncology Focused Investment Comes Into Its Own

Executive Summary

UBS closed its $471m Oncology Impact Fund, a specialist investment vehicle for early stage oncology, in April this year. But it was by no means the first commercial investment vehicle to focus solely on oncology. Nextech Invest raised its fourth oncology fund in July this year.

Advertisement

Related Content

Roche Commits Up To $1bn For Blueprint's Immunokinase Inhibitors

Topics

Advertisement
UsernamePublicRestriction

Register

SC097191

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel